Blog Archive

Blog Archive

Sunday, December 5, 2010

postheadericon Life sciences industry sending FDA a loud and clear message - anonymously

One of the key tasks of the incoming Congress is going to be reauthorization of PDUFA - the Prescription Drug User Fee Act. This Act provides key resources for the FDA to review and approve safe and effective new products. PDUFA expires in September in 2012, but the heavy lifting is going to begin in 2011, as the new GOP Congress selects Chairmen, picks keys staff, and starts setting its agenda for the 112th Congress.

Read more...

0 ความคิดเห็น: